• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME BIOSURGERY (RIDGEFIELD) SYNVISC; INTRA-ARTICULAR HYALURONIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME BIOSURGERY (RIDGEFIELD) SYNVISC; INTRA-ARTICULAR HYALURONIC ACID Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem No Information (3190)
Event Type  Injury  
Event Description
This unsolicited device case from united states was rec'd on (b)(6) 2014 from a physician.This case concerns a pt (demographics not provided) who was hospitalized while receiving treatment with synvisc injection.No relevant medical history, past drugs, concomitant medications and concurrent conditions were reported.On an unk date, pt started treatment with synvisc injection, (route, dosage regimen, batch/lot number and expiration date: not provided) into unspecified location for an unk indication.It was reported that the pt was hospitalized on an unk date during the time between the shots were given and therefore could not get the third injection.It was reported the pt was unable to continue the treatment.Action taken: stopped temporarily.Corrective treatment: not reported.Outcome: unk.A pharmaceutical technical complaint (ptc) was initiated and results were pending for the same.
 
Manufacturer Narrative
Pharmacovigilance comment: sanofi company comment dated (b)(4) 2014: this case concerns a pt who was hospitalized (unspecified) after receiving synvisc for unk indication.Although the role of device cannot be ruled out based on the device event temporal relationship; however, lack of detailed info about medical history, lab data, any concurrent medical illnesses, clinical course etc.Of the pt precludes a comprehensive assessment in this case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC
Type of Device
INTRA-ARTICULAR HYALURONIC ACID
Manufacturer (Section D)
GENZYME BIOSURGERY (RIDGEFIELD)
ridgefield NJ
Manufacturer Contact
michael murphy
55 corporate drive
mail stop: 55d-205a
bridgewater, NJ 08807
9089813633
MDR Report Key3848481
MDR Text Key4614871
Report Number2246315-2014-62892
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P940015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 05/07/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/21/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Is the Reporter a Health Professional? Yes
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PREV MEDS =UNK; CON MEDS =UNK
Patient Outcome(s) Hospitalization;
-
-